The Fox Chase Cancer Center senior director of community outreach recently co-authored a paper on ways to decrease cancer care disparities in medically underserved communities in America. Here, she shares some strategies.
NextHealth PHL covers the healthcare industry in Philadelphia and the work of scientists, doctors, and healthcare companies in Cellicon Valley. NextHealth PHL puts a special emphasis on healthcare news in the vibrant cell and gene therapies sector.
NextUp: The Navy Yard-Based Biopharma Company Engineering T-Cell Receptors to Destroy Cancerous Solid Tumors
After promising Phase II data, Adaptimmune is on track to file their drug candidate, afami-cel, for FDA approval next year.
The Northeast Philadelphia cancer center will offer Abecma — a CAR T-cell therapy targeting myeloma cells — to patients who have previously tried at least four different treatments.
The new collaboration between CHOP, the Netter Center, and Uplift seeks to help children in West and Southwest Philly and their families cope with trauma from community violence and the pandemic.
The Fox Chase Cancer Center senior director of community outreach recently co-authored a paper on ways to decrease cancer care disparities in medically underserved communities in America.
The Penn Neuro COVID Clinic provides evaluations, screenings, and referrals for COVID-related neurological complications like brain fog and vertigo.
Aro Biotherapeutics’ gene medicine platform uses Centyrin, an engineered human protein, to attack and treat disease with more precision.
Interius BioTherapeutics just raised $76 million in seed funding to advance their clinical testing.
Directed by critical care doctor Renyu Liu, Wake Up Stroke 120 won Best Short Narrative Film and the Humanitarian Award at this year’s New York City International Film Festival.
Scientists from Temple’s Lewis Katz School of Medicine and local biopharma company Neuropathix are testing their compound, KLS-13019, which is intended to target chemotherapy-induced pain in cancer patients.
From why Philly is a great place to start a life sciences company to the ways the industry can be more inclusive, here’s what the experts had to say during this year’s virtual Philly Tech Week.
WindMIL Therapeutics is targeting marrow-infiltrating lymphocytes (MILs) to create a treatment to destroy cancer cells in patients, no matter their tumor type.
The FDA is expected to expand emergency use of the Pfizer COVID-19 vaccine to adolescents as young as 12.
After decades of struggle, we’re finally seeing real-world, life-changing applications right here in Philadelphia. Has medicine finally got gene therapy right?
The fast-acting sensor is designed to identify the presence of SARS-CoV-2 from exhaled breath in 10 minutes.
Composed of three monoclonal antibodies, Immunome’s IMM-BCP-01 has demonstrated strong performance in preclinical testing.